Graham Doyle
Stock Analyst at UBS
(1.49)
# 3,639
Out of 5,125 analysts
409
Total ratings
51.1%
Success rate
-0.1%
Average return
Main Sectors:
Stocks Rated by Graham Doyle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: SHL Siemens Healthineers AG | Reiterated: Hold | €38.00 | €42.94 | -11.50% | 50 | Nov 5, 2026 | |
| ETR: FME Fresenius Medical Care AG | Reiterated: Sell | €36.00 | €40.72 | -11.59% | 58 | Nov 3, 2026 | |
| GEHC GE HealthCare Technologies | Rated: Hold | $73 → $80 | $83.65 | -4.36% | 12 | Nov 3, 2026 | |
| AMS: PHIA Koninklijke Philips N.V. | Reiterated: Hold | €24.00 | €27.06 | -11.31% | 55 | Nov 3, 2026 | |
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €56.00 | €53.47 | +4.73% | 50 | Sep 17, 2026 | |
| SWX: STMN Straumann Holding AG | Upgraded: Buy | CHF 90.00 → CHF 115.00 | CHF 106.85 | +7.63% | 17 | Sep 1, 2026 | |
| LON: SN Smith & Nephew plc | Reiterated: Hold | 1,300p → 1,120p | 1,139p | -1.62% | 21 | Aug 25, 2026 | |
| ETR: OBCK Ottobock SE & Co. KGaA | Reiterated: Buy | €74.00 → €78.00 | €46.40 | +68.10% | 6 | Aug 24, 2026 | |
| SWX: ALC Alcon Inc. | Reiterated: Buy | CHF 86.00 → CHF 83.00 | CHF 61.88 | +34.13% | 30 | Aug 14, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Downgraded: Sell | €25.00 → €22.60 | €33.74 | -33.02% | 54 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 375p | 249p | +50.84% | 22 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 151.00 → CHF 148.00 | CHF 109.60 | +35.04% | 6 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | kr 39.00 | kr 62.15 | -37.25% | 1 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 215.00 | CHF 280.40 | -23.32% | 15 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $134.48 | n/a | 2 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13,884.00 | n/a | 5 | May 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1,917.00 | n/a | 3 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €90.00 | €57.08 | n/a | 1 | Jan 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 275.00 | CHF 401.80 | n/a | 1 | Jun 20, 2019 |
Siemens Healthineers AG
Nov 5, 2026
Reiterated: Hold
Price Target: €38.00
Current: €42.94
Upside: -11.50%
Fresenius Medical Care AG
Nov 3, 2026
Reiterated: Sell
Price Target: €36.00
Current: €40.72
Upside: -11.59%
GE HealthCare Technologies
Nov 3, 2026
Rated: Hold
Price Target: $73 → $80
Current: $83.65
Upside: -4.36%
Koninklijke Philips N.V.
Nov 3, 2026
Reiterated: Hold
Price Target: €24.00
Current: €27.06
Upside: -11.31%
Fresenius SE & Co. KGaA
Sep 17, 2026
Reiterated: Buy
Price Target: €56.00
Current: €53.47
Upside: +4.73%
Straumann Holding AG
Sep 1, 2026
Upgraded: Buy
Price Target: CHF 90.00 → CHF 115.00
Current: CHF 106.85
Upside: +7.63%
Smith & Nephew plc
Aug 25, 2026
Reiterated: Hold
Price Target: 1,300p → 1,120p
Current: 1,139p
Upside: -1.62%
Ottobock SE & Co. KGaA
Aug 24, 2026
Reiterated: Buy
Price Target: €74.00 → €78.00
Current: €46.40
Upside: +68.10%
Alcon Inc.
Aug 14, 2026
Reiterated: Buy
Price Target: CHF 86.00 → CHF 83.00
Current: CHF 61.88
Upside: +34.13%
Carl Zeiss Meditec AG
Aug 11, 2026
Downgraded: Sell
Price Target: €25.00 → €22.60
Current: €33.74
Upside: -33.02%
Aug 6, 2026
Reiterated: Buy
Price Target: 375p
Current: 249p
Upside: +50.84%
Jul 21, 2026
Reiterated: Hold
Price Target: CHF 151.00 → CHF 148.00
Current: CHF 109.60
Upside: +35.04%
May 21, 2026
Downgraded: Sell
Price Target: kr 39.00
Current: kr 62.15
Upside: -37.25%
Mar 24, 2026
Reiterated: Hold
Price Target: CHF 215.00
Current: CHF 280.40
Upside: -23.32%
Jan 25, 2022
Downgraded: Hold
Price Target: n/a
Current: $134.48
Upside: n/a
May 29, 2020
Reiterated: Buy
Price Target: n/a
Current: $13,884.00
Upside: n/a
May 28, 2020
Reiterated: Hold
Price Target: n/a
Current: $1,917.00
Upside: n/a
Jan 22, 2020
Reiterated: Buy
Price Target: €90.00
Current: €57.08
Upside: n/a
Jun 20, 2019
Downgraded: Hold
Price Target: CHF 275.00
Current: CHF 401.80
Upside: n/a